1. Home
  2. WFCF vs BTAI Comparison

WFCF vs BTAI Comparison

Compare WFCF & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Where Food Comes From Inc.

WFCF

Where Food Comes From Inc.

N/A

Current Price

$12.14

Market Cap

57.5M

Sector

Technology

ML Signal

N/A

Logo BioXcel Therapeutics Inc.

BTAI

BioXcel Therapeutics Inc.

N/A

Current Price

$1.56

Market Cap

35.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WFCF
BTAI
Founded
1996
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.5M
35.6M
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
WFCF
BTAI
Price
$12.14
$1.56
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$25.33
AVG Volume (30 Days)
1.5K
1.1M
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.30
N/A
Revenue
$20,774,416.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$261.81
P/E Ratio
$40.47
N/A
Revenue Growth
16.69
N/A
52 Week Low
$9.69
$1.17
52 Week High
$13.70
$8.08

Technical Indicators

Market Signals
Indicator
WFCF
BTAI
Relative Strength Index (RSI) 54.77 46.64
Support Level $11.90 $1.50
Resistance Level $12.40 $2.18
Average True Range (ATR) 0.23 0.14
MACD 0.00 0.00
Stochastic Oscillator 46.88 31.58

Price Performance

Historical Comparison
WFCF
BTAI

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.

About BTAI BioXcel Therapeutics Inc.

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

Share on Social Networks: